Found: 18
Select item for more details and to access through your institution.
Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad511
- By:
- Publication type:
- Article
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
- Published in:
- AIDS & Behavior, 2023, v. 27, n. 9, p. 3027, doi. 10.1007/s10461-023-04025-z
- By:
- Publication type:
- Article
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ß<sub>3</sub>-adrenoceptor agonist for treatment of overactive bladder.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2012, v. 50, n. 11, p. 838, doi. 10.5414/CP201782
- By:
- Publication type:
- Article
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
- Published in:
- PLoS Medicine, 2024, v. 21, n. 3, p. 1, doi. 10.1371/journal.pmed.1004360
- By:
- Publication type:
- Article
Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112303
- By:
- Publication type:
- Article
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.
- Published in:
- PLoS Pathogens, 2021, p. 1, doi. 10.1371/journal.ppat.1009363
- By:
- Publication type:
- Article
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-57491-z
- By:
- Publication type:
- Article
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 519, p. 1, doi. 10.1126/scitranslmed.aaw1673
- By:
- Publication type:
- Article
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 510, p. 1, doi. 10.1126/scitranslmed.aax1880
- By:
- Publication type:
- Article
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 9, p. 1365, doi. 10.3390/v16091365
- By:
- Publication type:
- Article
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
- Published in:
- PLoS Medicine, 2020, v. 17, n. 5, p. 1, doi. 10.1371/journal.pmed.1003117
- By:
- Publication type:
- Article
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Protein Dose-Sparing Effect of AS01<sub>B</sub> Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e405, doi. 10.1093/infdis/jiad434
- By:
- Publication type:
- Article
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0179597
- By:
- Publication type:
- Article